Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 1 result.

- Journal article
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
Limentani, Steven A Campone, Mario Dorval, Thierry Curigliano, Giuseppe de Boer, Richard Vogel, Charles White, Shane Bachelot, Thomas Canon, Jean-Luc Disis, Mary Awada, Ahmad Berlière, Martine[UCL] Amant, Frédéric Levine, Ellis Burny, Wivine Callegaro, Andrea de Sousa Alves, Pedro Miguel Louahed, Jamila Brichard, Vincent Lehmann, Frédéric F (2016) Breast Cancer Research and Treatment — Vol. 156, no.2, p. 319-330 (2016)